1
|
Dimou M, Iliakis T, Paradalis V, Bitsani A, Kyrtsonis M, Panayiotidis P. Complete eradication of chronic lymphocytic leukemia with unusual skin involvement of high mitotic index after time-limited venetoclax/obinutuzumab treatment. Clin Case Rep 2021; 9:e04514. [PMID: 34322260 PMCID: PMC8299089 DOI: 10.1002/ccr3.4514] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/04/2021] [Accepted: 06/09/2021] [Indexed: 11/30/2022] Open
Abstract
The novel time-limited combinations with the bcl-2 inhibitor venetoclax can induce deep responses even in CLL cases with unusual and biologically aggressive presentations, like the skin masses of our patient.
Collapse
Affiliation(s)
- Maria Dimou
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| | - Theodoros Iliakis
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| | - Vasileios Paradalis
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| | - Aikaterini Bitsani
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| | - Marie‐Christine Kyrtsonis
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| | - Panayiotis Panayiotidis
- First Department of Internal Medicine, Propaedeutic, Hematology Clinical Trial UnitLaiko General HospitalAthensGreece
| |
Collapse
|
2
|
Dimou M, Bitsani A, Roumelioti M, Dimitrakopoulou A, Iliakis T, Pardalis V, Grafakos I, Kalyva S, Markopoulos A, Kyrtsonis M, Panayiotidis P. Richter's transformation as leptomeningeal infiltration in a chronic lymphocytic leukemia patient receiving venetoclax. Could blood-brain barrier be a disease "sanctuary" during venetoclax treatment? Clin Case Rep 2021; 9:2249-2253. [PMID: 33936674 PMCID: PMC8077271 DOI: 10.1002/ccr3.4002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2021] [Accepted: 02/16/2021] [Indexed: 11/17/2022] Open
Abstract
Our unique case of Richter's Transformation presenting as leptomeningial infiltration in a CLL patient receiving venetoclax raises questions on whether the drug penetrates the blood-brain barrier and at what extend, especially in reduced doses given for drug-drug interactions.
Collapse
Affiliation(s)
- Maria Dimou
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Aikaterini Bitsani
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Maria Roumelioti
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Aglaia Dimitrakopoulou
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Theodore Iliakis
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Vasileios Pardalis
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Ioannis Grafakos
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Sotiria Kalyva
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Athanasios Markopoulos
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Marie‐Christine Kyrtsonis
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| | - Panayiotis Panayiotidis
- 1 Propedeutic Internal Medicine ClinicHematology Department and Molecular Laboratory in HematologyNational and Kapodistrian University of AthensAthensGreece
| |
Collapse
|
3
|
Terpos E, Symeonidis A, Delimpasi S, Zamagni E, Katodritou E, Rivolti E, Kyrtsonis M, Fotiou D, Kanellias N, Migkou M, Roussou M, Gavriatopoulou M, Hatjiharissi E, Cavo M, Dimopoulos M. Efficacy and safety of daratumumab with dexamethasone in patients with relapsed/refractory multiple myeloma and severe renal impairment: results of the phase 2 dare study. Hematol Transfus Cell Ther 2020. [DOI: 10.1016/j.htct.2020.09.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
4
|
Asimakopoulos JV, Angelopoulou MK, Arapaki M, Kanellopoulos A, Dimou M, Giakoumis X, Konstantinou E, Belia M, Chatzidimitriou C, Sachanas S, Iliakis T, Kyrtsonis M, Siakantaris MP, Viniou N, Variamis E, Kontopidou FN, Pangalis GA, Panayiotidis P, Konstantopoulos K, Vassilakopoulos TP. Validation of the simplified International Prognostic Score3 in a Hellenic cohort of patients with advanced‐stage Hodgkin‐lymphoma. Br J Haematol 2020; 190:e335-e339. [DOI: 10.1111/bjh.16903] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2020] [Accepted: 05/29/2020] [Indexed: 11/26/2022]
Affiliation(s)
- John V. Asimakopoulos
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Maria K. Angelopoulou
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Maria‐Panagiota Arapaki
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Alexandros Kanellopoulos
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Maria Dimou
- 1st Propedeutic Department of Internal Medicine National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Xanthoula Giakoumis
- Department of Haematology Athens Medical Center Psychikon Branch Athens Greece
| | - Eliana Konstantinou
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Marina Belia
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Chrysovalantou Chatzidimitriou
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Sotirios Sachanas
- Department of Haematology Athens Medical Center Psychikon Branch Athens Greece
| | - Theodoros Iliakis
- 1st Propedeutic Department of Internal Medicine National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Marie‐Christine Kyrtsonis
- 1st Propedeutic Department of Internal Medicine National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Marina P. Siakantaris
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Nora‐Athina Viniou
- 1st Department of Internal Medicine Hematology Unit, National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Eleni Variamis
- 1st Department of Internal Medicine Hematology Unit, National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Flora N. Kontopidou
- Second Department of Internal Medicine National and Kapodistrian University of Athens Hippokration General Hospital Athens Greece
| | | | - Panayiotis Panayiotidis
- 1st Propedeutic Department of Internal Medicine National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Kostas Konstantopoulos
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| | - Theodoros P. Vassilakopoulos
- Department of Haematology and Bone Marrow Transplantation Unit National and Kapodistrian University of Athens School of Medicine Laikon General Hospital Athens Greece
| |
Collapse
|
5
|
Katodritou E, Kastritis E, Gatt M, Cohen YC, Avivi I, Pouli A, Lalayianni C, Lavi N, Delimpasis S, Kyrtsonis M, Michael M, Suriu C, Miri Z, Tzafarti K, Vadikoliou C, Maltezas D, Zikos P, Ganzel C, Vaxman Y, Aviv A, Christoforidou A, Gavriatopoulou M, Shaulov A, Verrou E, Papanota A, Fakinos G, Gkioka A, Palaska V, Triantafyllou T, Konstantinidou P, Anagnostopoulos A, Terpos E, Dimopoulos MA. Real-world data on incidence, clinical characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) in the era of novel therapies: A study of the Greco-Israeli collaborative myeloma working group. Am J Hematol 2020; 95:465-471. [PMID: 32048329 DOI: 10.1002/ajh.25755] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2019] [Revised: 01/14/2020] [Accepted: 01/21/2020] [Indexed: 01/22/2023]
Abstract
We investigated incidence, characteristics and outcome of patients with macrofocal multiple myeloma (MFMM) treated mainly with novel therapies. Based on definition (BMPCs <20% and lytic lesions/plasmacytomas, without anemia, renal insufficiency or hypercalcemia) we identified 140 patients with MFMM, among 4650 myeloma patients (3%). Twice the number of patients with typical myeloma were used as controls; 60% were <65 years and 70% had advanced bone disease. Plasmacytomas were more frequent in MFMM compared with standard myeloma (68% vs 15%, P < .05). Adverse prognostic parameters (high lactate dehydrogenase, advanced stage, high risk cytogenetics, immunoparesis) were less common in patients with MFMM compared with controls (P < .05); 90% received novel agents and 47% underwent autologous transplantation upfront; 90% achieved an objective response; 70% had at least very good partial response which was significantly higher compared with controls (P < .05). After a median follow-up of 52 months, 33 patients have died. Early death (<12 months) was infrequent in MFMM. Median progression-free survival and overall survival (OS) were 46 and 129 months respectively, both significantly longer compared with controls (P < .001). Proteasome inhibitor (PI)-based therapy was the only independent predictor for OS in the multivariate analysis (HR: 3.9; P < .001). In conclusion, MFMM is a distinct entity presented in young and elderly subjects, characterized by limited bone marrow infiltration, advanced bone disease and frequent presence of plasmacytomas; MFMM patients have less often adverse prognostic features and achieve excellent responses and prolonged OS especially when treated with PI-based therapies. Novel imaging will help in a more accurate classification of this entity.
Collapse
Affiliation(s)
- Eirini Katodritou
- Department of Hematology“Theagenion” Cancer Hospital Thessaloniki Greece
| | - Efstathios Kastritis
- Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, School of Medicine Athens Greece
| | - Moshe Gatt
- Department of HematologyHadassah Hebrew University Medical Center Jerusalem Israel
| | - Yael C. Cohen
- Department of HematologyTel Aviv Sourasky Medical Center and Sackler faculty of Medicine, Tel Aviv University Tel Aviv Israel
| | - Irit Avivi
- Department of HematologyTel Aviv Sourasky Medical Center and Sackler faculty of Medicine, Tel Aviv University Tel Aviv Israel
| | - Anastasia Pouli
- Hematology Department“St Savvas” Oncology Hospital Athens Greece
| | - Chrysavgi Lalayianni
- Department of Hematology and Bone Marrow Transplantation UnitGeorge Papanicolaou Hospital Thessaloniki Greece
| | - Noa Lavi
- Department of HematologyRambam Medical Center Haifa Israel
| | - Sosana Delimpasis
- Department of Hematology and Bone Marrow Transplantation UnitEvangelismos Hospital Athens Greece
| | - Marie‐Christine Kyrtsonis
- First Department of Propaedeutic Internal MedicineNational and Kapodistrian University of Athens, Laikon General Hospital Athens Greece
| | | | - Celia Suriu
- Department of HematologyGalilee Medical Center Naharia Israel
- Department of HematologyThe Azrieli Faculty of Medicine, Bar‐Ilan University Safed Israel
| | - Zektser Miri
- Department of HematologySoroka Medical Center Beer Sheva Israel
| | - Katrin Tzafarti
- Department of HematologyAsaf Harofe Medical Center Sackler faculty of Medicine, Tel Aviv University, Be'er Ya'akov Israel
| | - Chrysanthi Vadikoliou
- Department of Hematology and Bone Marrow Transplantation UnitGeorge Papanicolaou Hospital Thessaloniki Greece
| | | | | | - Chezi Ganzel
- Department of HematologyShaare Zedek Medical Center Jerusalem Israel
| | - Yuliana Vaxman
- Department of HematologyRabin Medical Center Petah Tikva Israel
| | | | - Anna Christoforidou
- Department of HematologyDimokrition University of Alexandroupolis Alexandroupoli Greece
| | - Maria Gavriatopoulou
- Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, School of Medicine Athens Greece
| | - Adir Shaulov
- Department of HematologyHadassah Hebrew University Medical Center Jerusalem Israel
| | - Evgenia Verrou
- Department of Hematology“Theagenion” Cancer Hospital Thessaloniki Greece
| | - Aristea‐Maria Papanota
- Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, School of Medicine Athens Greece
| | - Gabriel Fakinos
- Hematology Department“St Savvas” Oncology Hospital Athens Greece
| | - Annita‐Ioanna Gkioka
- First Department of Propaedeutic Internal MedicineNational and Kapodistrian University of Athens, Laikon General Hospital Athens Greece
| | - Vasiliki Palaska
- Department of Hematology“Theagenion” Cancer Hospital Thessaloniki Greece
| | | | | | - Achilles Anagnostopoulos
- Department of Hematology and Bone Marrow Transplantation UnitGeorge Papanicolaou Hospital Thessaloniki Greece
| | - Evangelos Terpos
- Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, School of Medicine Athens Greece
| | - Meletios A. Dimopoulos
- Department of Clinical TherapeuticsNational and Kapodistrian University of Athens, School of Medicine Athens Greece
| |
Collapse
|
6
|
Nicolatou‐Galitis O, Papadopoulou E, Vardas E, Kouri M, Galiti D, Galitis E, Alexiou K, Tsiklakis K, Ardavanis A, Razis E, Athanasiadis I, Droufakou S, Psyrri A, Karamouzis MV, Linardou H, Daliani D, Tzanninis D, Sachanas S, Laschos K, Kyrtsonis M, Antoniou F, Laskarakis A, Giassas S, Nikolaidi A, Rigakos G, Ntokou A, Migliorati CA, Ripamonti CI. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone‐targeting agents. Oral Dis 2020; 26:955-966. [DOI: 10.1111/odi.13294] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2019] [Revised: 12/26/2019] [Accepted: 01/28/2020] [Indexed: 12/20/2022]
Affiliation(s)
- Ourania Nicolatou‐Galitis
- Clinic of Hospital Dentistry Densstal School National & Kapodistrian University of Athens Athens Greece
| | - Erofili Papadopoulou
- Clinic of Hospital Dentistry Densstal School National & Kapodistrian University of Athens Athens Greece
| | - Emmanouil Vardas
- Clinic of Hospital Dentistry Densstal School National & Kapodistrian University of Athens Athens Greece
| | - Maria Kouri
- Clinic of Hospital Dentistry Densstal School National & Kapodistrian University of Athens Athens Greece
| | - Dimitra Galiti
- Clinic of Oral Diagnosis & Radiology Dental School National & Kapodistrian University of Athens Athens Greece
| | - Evangelos Galitis
- Clinic of Oral and Maxillofacial Surgery Dental School National & Kapodistrian University of Athens Athens Greece
| | - Konstantina‐Eleni Alexiou
- Clinic of Oral Diagnosis & Radiology Dental School National & Kapodistrian University of Athens Athens Greece
| | - Kostas Tsiklakis
- Clinic of Oral Diagnosis & Radiology Dental School National & Kapodistrian University of Athens Athens Greece
| | | | - Evangelia Razis
- Third Medical Oncology Department Hygeia Hospital Athens Greece
| | | | | | - Amanda Psyrri
- Attikon Hospital National and Kapodistrian University of Athens Athens Greece
| | - Michalis V. Karamouzis
- Department of Biological Chemistry and First Department of Internal Medicine Laikon Hospital, Medical School National and Kapodistrian University of Athens Athens Greece
| | | | - Danai Daliani
- First Medical Oncology Department Euroclinic of Athens Athens Greece
| | | | - Sotirios Sachanas
- Department of Hematology Athens Medical Center Psychikon Branch Athens Greece
| | - Konstantinos Laschos
- 2nd Oncology Department General and Oncologic Hospital “Agii Anargyri” Athens Greece
| | | | - Fotini Antoniou
- Department of Oncology Unit Elena Venizelou Maternity Hospital Athens Greece
| | | | - Styllianos Giassas
- 2nd Oncology Clinic IASO Maternity Hospital and 3rd Oncology Clinic Metropolitan General Hospital Athens Greece
| | | | - George Rigakos
- Third Medical Oncology Department Hygeia Hospital Athens Greece
| | - Anna Ntokou
- Oncology Department Saint Savvas Hospital Athens Greece
| | - Cesar A. Migliorati
- Department of Diagnostic Sciences and Oral Medicine University of Florida Health Science Center College of Dentistry Gainesville FL USA
| | - Carla I. Ripamonti
- Supportive Care Unit Department of Medical Oncology and Haematology Fondazione IRRCS Istituto Nazionale dei Tumori Milano Italy
| |
Collapse
|
7
|
Kalpadakis C, Pangalis G, Konstantinou E, Vassilakopoulos T, Telonis V, Sachanas S, Tsirkinidis P, Moschogiannis M, Yiakoumis X, Siakantaris M, Tsaftaridis P, Iliakis T, Befani M, Kyrtsonis M, Dimitrakopoulou A, Boutsikas G, Korkolopoulou P, Kontopidou F, Koulieris E, Pontikoglou C, Ximeri M, Psylaki M, Roumelioti M, Rontogiannis D, Papadaki H, Panagiotidis P, Angelopoulou M. CLONAL B-CELL LYMPHOCYTOSIS OF MARGINAL ZONE ORIGIN (CBL-MZ): DESCRIPTION OF MAIN CLINICAL FEATURES, DISEASE EVOLUTION AND OUTCOME IN A SERIES OF 100 PATIENTS. Hematol Oncol 2019. [DOI: 10.1002/hon.38_2630] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- C. Kalpadakis
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - G.A. Pangalis
- Department of Haematology; Athens Medical Center; Athens Greece
| | - E. Konstantinou
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - T.P. Vassilakopoulos
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - V. Telonis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - S. Sachanas
- Department of Haematology; Athens Medical Center; Athens Greece
| | - P. Tsirkinidis
- Department of Haematology; Athens Medical Center; Athens Greece
| | | | - X. Yiakoumis
- Department of Haematology; Athens Medical Center; Athens Greece
| | - M. Siakantaris
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - P. Tsaftaridis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - T. Iliakis
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - M. Befani
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - M. Kyrtsonis
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - A. Dimitrakopoulou
- Immunology Laboratory; University of Athens, Laikon General Hospital; Athens Greece
| | - G. Boutsikas
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| | - P. Korkolopoulou
- Department of Pathology; University of Athens, Laikon General Hospital; Athens Greece
| | - F. Kontopidou
- Second Department of Internal Medicine; Hippokrateio General Hospital, University of Athens; Athens Greece
| | - E. Koulieris
- Department of Haematology; Athens Medical Center; Athens Greece
| | - C. Pontikoglou
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Ximeri
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Psylaki
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - M. Roumelioti
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - D. Rontogiannis
- Department of Anatomic Pathology; Evangelismos General Hospital; Athens Greece
| | - H. Papadaki
- Department of Haematology; University Hospital, University of Crete; Heraklion Crete Greece
| | - P. Panagiotidis
- 1st Department of Propedeutics; University of Athens, Laikon General Hospital; Athens Greece
| | - M.K. Angelopoulou
- Department of Haematology; University of Athens, Laikon General Hospital; Athens Greece
| |
Collapse
|
8
|
Angelopoulou MK, Vassilakopoulos TP, Batsis I, Sakellari I, Gkirkas K, Pappa V, Giannoulia P, Apostolidis I, Apostolopoulos C, Roussou P, Panayiotidis P, Dimou M, Kyrtsonis M, Palassopoulou M, Vassilopoulos G, Moschogiannis M, Kalpadakis C, Margaritis D, Spyridonidis A, Michalis E, Anargyrou K, Repousis P, Hatzimichael E, Bousiou Z, Poulakidas E, Grentzelias D, Harhalakis N, Pangalis GA, Anagnostopoulos A, Tsirigotis P. Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience. Hematol Oncol 2018; 36:174-181. [PMID: 28219112 PMCID: PMC5836920 DOI: 10.1002/hon.2383] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2016] [Revised: 12/02/2016] [Accepted: 12/09/2016] [Indexed: 01/24/2023]
Abstract
This retrospective study aimed to describe the Hellenic experience on the use of brentuximab vedotin (BV) in relapsed/refractory (R/R) Hodgkin lymphoma (HL) given within its indication. From June 2011 to April 2015, ninety-five patients with R/R HL, who received BV in 20 centers from Greece, were analyzed. Their median age was 33 years, and 62% were males. Sixty-seven patients received BV after autologous stem cell transplantation failure, whereas 28 patients were treated with BV without a prior autologous stem cell transplantation, due to advanced age/comorbidities or chemorefractory disease. The median number of prior treatments was 4 and 44% of the patients were refractory to their most recent therapy. The median number of BV cycles was 8 (range, 2-16), and the median time to best response was the fourth cycle. Fifty-seven patients achieved an objective response: twenty-two (23%), a complete response (CR), and 35 patients (37%), a partial, for an overall response rate of 60%. Twelve patients (13%) had stable disease, and the remaining twenty-six (27%) had progressive disease as their best response. At a median follow-up of 11.5 months, median progression-free survival and overall survival were 8 and 26.5 months, respectively. Multivariate analysis showed that chemosensitivity to treatment administered before BV was associated with a significantly increased probability of achieving response to BV (P = .005). Bulky disease (P = .01) and response to BV (P <.001) were significant for progression-free survival, while refractoriness to most recent treatment (P = .04), bulky disease (P = .005), and B-symptoms (P = .001) were unfavorable factors for overall survival. Among the 22 CRs, 5 remain in CR with no further treatment after BV at a median follow-up of 13 months. In conclusion, our data indicate that BV is an effective treatment for R/R HL patients even outside clinical trials. Whether BV can cure a fraction of patients remains to be seen.
Collapse
Affiliation(s)
- Maria K. Angelopoulou
- Department of Hematology, Laikon General HospitalNational and Kapodistrian University of AthensAthensGreece
| | | | - Ioannis Batsis
- Hematology and Bone Marrow Transplantation DepartmentGeneral Hospital of Thessaloniki PapanikolaouThessalonikiGreece
| | - Ioanna Sakellari
- Hematology and Bone Marrow Transplantation DepartmentGeneral Hospital of Thessaloniki PapanikolaouThessalonikiGreece
| | - Konstantinos Gkirkas
- 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Vasiliki Pappa
- 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | | | | | - Christos Apostolopoulos
- Third Department of Medicine, “Sotiria” General Hospital of Thoracic Diseases, Hematology UnitNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Paraskevi Roussou
- Third Department of Medicine, “Sotiria” General Hospital of Thoracic Diseases, Hematology UnitNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Panayiotis Panayiotidis
- 1st Department of Propedeutic Internal Medicine, Laikon General HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Maria Dimou
- 1st Department of Propedeutic Internal Medicine, Laikon General HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Marie‐Christine Kyrtsonis
- 1st Department of Propedeutic Internal Medicine, Laikon General HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| | - Maria Palassopoulou
- Department of Hematology, Larissa University HospitalUniversity of ThessaliaLarissaGreece
| | - Georgios Vassilopoulos
- Department of Hematology, Larissa University HospitalUniversity of ThessaliaLarissaGreece
| | | | - Christina Kalpadakis
- Department of Hematology, Heraklion University HospitalUniversity of CreteHeraklionGreece
| | - Dimitrios Margaritis
- Department of HematologyDemocritus University of Thrace Medical SchoolAlexandroupolisGreece
| | | | - Eurydiki Michalis
- Department of Clinical Hematology“G.Gennimatas” Athens General HospitalAthensGreece
| | | | | | | | - Zoi Bousiou
- Hematology and Bone Marrow Transplantation DepartmentGeneral Hospital of Thessaloniki PapanikolaouThessalonikiGreece
| | - Elias Poulakidas
- Department of Hematology401 Military Hospital of AthensAthensGreece
| | | | | | - Gerassimos A. Pangalis
- Department of HematologyDemocritus University of Thrace Medical SchoolAlexandroupolisGreece
| | - Achilles Anagnostopoulos
- Hematology and Bone Marrow Transplantation DepartmentGeneral Hospital of Thessaloniki PapanikolaouThessalonikiGreece
| | - Panagiotis Tsirigotis
- 2nd Department of Internal Medicine, Faculty of Medicine, ATTIKON General University HospitalNational and Kapodistrian University of Athens, Medical SchoolAthensGreece
| |
Collapse
|